Literature DB >> 772329

Angioimmunoblastic lymphadenopathy.

S B Moor, E G Harrison, L H Weiland.   

Abstract

Forteen cases of angioimmunoblastic lymphadenopathy were reviewed retrospectively, and histologic material was examined by various staining and histochemical techniques. The predominant morphologic features were effacement of nodal architecture, microvascular proliferation, and a polymorphous cellular infiltrate of immunoblasts, plasma cells, lymphocytes, and eosinophils. Immunofluorescence studies suggested the presence of cells elaborating a variety of immune globulins with an unpredictable pattern. The clinical course and treatment varied, perhaps partly reflecting the initial spectrum of diagnoses made in these cases before angioimmunoblastic lymphadenopathy was defined. Because systemic infection appears to be a major factor in the deaths of these patients whose immune competence is uncertain, the usual chemotherapy for malignant lymphomas may be too vigorous for this condition. At present, the cause of the condition is unknown.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 772329

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  A case of angioimmunoblastic lymphadenopathy with involvement of the nervous system.

Authors:  R Schober
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

2.  Angioimmunoblastic lymphadenopathy. Fine structure of the lymph nodes by correction of light and electron microscopical findings.

Authors:  U Schnaidt; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  Immunoblastic lymphadenopathy: case report and literature review.

Authors:  A A Cooperberg; M B de Champlain; J Siminovitch; A Rosenberg; J P Schwartz
Journal:  Can Med Assoc J       Date:  1977-07-09       Impact factor: 8.262

4.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

Authors:  H Knecht; E W Schwarze; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

7.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

8.  Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and sicca syndrome.

Authors:  Y J Bignon; A Janin-Mercier; J J Dubost; J M Ristori; Y Fonck; J C Alphonse; B J Sauvezie
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

9.  Angioimmunoblastic lymphadenopathy associated with polyarthritis.

Authors:  R S Rothwell; M J Mant; P Davis
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.